文献速递心脑血管急症

补充维生素B对卒中复发的预防作用:一项Meta分析

[Preventive effect of Vitamin B supplementation on recurrent stroke: a Meta-analysis].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2017-01-01
一句话结论在卒中患者中,补充维生素B与复发卒中风险降低相关(RR=0.64,95%CI 0.47-0.87),并可显著降低血浆同型半胱氨酸水平。

该Meta分析纳入7项随机对照试验,共9846例卒中患者(对照组4755例,试验组5091例),评估补充维生素B对缺血性卒中复发的预防作用。结果显示,试验组复发卒中发生率显著低于对照组(RR=0.64,95%CI 0.47-0.87),但纳入文献存在异质性(I2=62.9%,P=0.009)和发表偏倚(Egger回归P=0.008,Begg回归P=0.035)。补充维生素B还可显著降低血浆同型半胱氨酸水平(WMD=-6.92,95%CI -9.11至-4.73),但异质性很高(I2=96.2%,P=0.000)。作者认为补充维生素B与卒中患者复发风险降低相关,并可能通过降低同型半胱氨酸水平发挥作用。

要点

  • 在卒中患者中,补充维生素B与复发卒中风险降低相关: pooled RR=0.64,95%CI 0.47-0.87。
  • 补充维生素B可显著降低卒中患者血浆同型半胱氨酸水平:WMD=-6.92,95%CI -9.11至-4.73。
  • 复发卒中结局存在异质性(I2=62.9%,P=0.009),采用随机效应模型合并。
  • 复发卒中结局存在发表偏倚:Egger回归P=0.008,Begg回归P=0.035。
  • 敏感性分析显示总体结果稳定可靠。

适用人群与场景

  • 卒中患者(7项随机对照试验共纳入9846例,对照组4755例,试验组5091例)。

处置流程与药物剂量

  • 对照组接受安慰剂或不含维生素B的基础治疗;试验组接受单独维生素B或常规治疗基础上加用维生素B。

研究设计与关键结果

  • 研究类型:Meta分析,纳入7项随机对照试验,检索数据库包括ScienceDirect、PubMed/Medline、中国知网、中国生物医学文献数据库、万方数据库和维普中文科技期刊数据库,检索截止2016年8月,纳入英文或中文文献。
  • 共纳入9846例卒中患者,对照组4755例,试验组5091例;采用改良Jadad量表评价研究质量,Stata 12.0进行Meta分析。
  • 主要终点复发卒中:试验组复发卒中发生率显著低于对照组,pooled RR=0.64,95%CI 0.47-0.87;异质性检验I2=62.9%,P=0.009,采用随机效应模型。
  • 累积Meta分析显示,从2012年起补充维生素B对预防卒中复发表现出积极效果,随着样本量增加95%CI趋于稳定。
  • 发表偏倚:漏斗图目测不对称,Egger回归P=0.008,Begg回归P=0.035,均P<0.05,提示存在发表偏倚;敏感性分析显示总体结果稳定可靠。
  • 次要终点血浆同型半胱氨酸水平:试验组补充维生素B后血浆同型半胱氨酸水平较对照组显著降低,pooled WMD=-6.92,95%CI -9.11至-4.73;异质性检验I2=96.2%,P=0.000,采用随机效应模型。
  • 同型半胱氨酸结局的发表偏倚:漏斗图目测对称,Egger回归P=0.345,Begg回归P=0.764,均P>0.05,提示无发表偏倚证据。

证据类型、等级与局限

  • 证据类型:Meta分析(纳入7项随机对照试验)。
  • 采用改良Jadad量表评价纳入研究质量。
  • 局限:复发卒中结局纳入文献存在异质性(I2=62.9%,P=0.009)。
  • 局限:复发卒中结局存在发表偏倚(Egger回归P=0.008,Begg回归P=0.035)。
  • 局限:同型半胱氨酸结局纳入文献存在异质性(I2=96.2%,P=0.000)。

对床旁实践的改变

  • 作者认为,补充维生素B与卒中患者复发风险降低相关,并可显著改善卒中二级预防质量。
  • 作者认为,补充维生素B可降低卒中患者血浆同型半胱氨酸水平,这可能有助于其预防卒中复发的作用。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate whether Vitamin B supplementation could prevent ischemic stroke recurrence.

METHODS: Randomized controlled trials (RCTs) observing Vitamin B supplementation in patients with stroke was performed in databases including ScienceDirect, PubMed/Medline, China National Knowledge Infrastructure, Chinese Biomedical Data-Base, Wanfang Database, and VIP Chinese Science and Technology Journal Database to find related studies in English or Chinese published before August 2016. The patients in control group received a placebo or basic therapy without Vitamin B, and those in experimental group was treated with Vitamin B alone or Vitamin B on the basis of conventional treatment. The data were collected by two researchers independently and the quality of studies was assessed by the modified Jadad Scale. The Meta-analysis was performed using Stata 12.0, funnel plot was drawn, and Egger and Begg regressions were used to evaluate the publication bias, and sensitivity was also analyzed.

RESULTS: Seven RCTs studies were enrolled to analyze with a total number of 9 846 stroke patients, 4 755 patients in control group, and 5 091 in experimental group, respectively. (1) Vitamin B supplementation for prevention of recurrent stroke: heterogeneity test results showed a heterogeneity in literatures enrolled (I2 = 62.9%, P = 0.009), and a random effect model was used for Meta-analysis. It was shown that the incidence of recurrent stroke in the experimental group was significantly lower than that in the control group [pooled relative risk (RR) = 0.64, 95% confidence interval (95%CI) = 0.47-0.87], which indicated that the supplementation of Vitamin B could prevent the recurrence of stroke. Cumulative Meta-analysis showed that Vitamin B supplementation exhibited positive effects in the prevention stroke recurrence from 2012. The 95%CI tended to be stable while demonstrating good change trend as sample growing. The publication bias evaluation results showed that the funnel plot was not symmetrical by visual inspection, further quantitative analysis showed that P value from Egger regression was 0.008, while that from Begg regression was 0.035, both P < 0.05, suggesting there were some publication bias. The sensitivity analysis showed that the overall results were stable and reliable. (2) The effect of Vitamin B supplementation on plasma homocysteine (Hcy) levels in stroke patients: heterogeneity test results showed a heterogeneity in literatures enrolled (I2 = 96.2%, P = 0.000), and a random effect model was used for Meta-analysis. It was shown that compared with control group, the plasma Hcy levels of patients after Vitamin B supplementation in experimental group were significantly decreased [pooled weighted mean difference (WMD) = -6.92, 95%CI = -9.11 to -4.73), indicating that Vitamin B could significantly reduce plasma Hcy levels in stroke patients. Cumulative meta analysis showed that, as time went on, the relevant research samples were increased, 95%CI tended to be stable and the variation tendency was better. The publication bias evaluation results showed that the funnel plot was symmetry by visual inspection, and further quantitative analysis showed that the P value from Egger regression was 0.345, and that from Begg regression was 0.764, both P > 0.05, which indicating that there was no evidence of publication bias in the study included.

CONCLUSIONS: Vitamin B supplementation was associated with a lower risk of recurrent stroke in stroke patients and could significantly improve the quality of secondary prevention of stroke. Furthermore, supplementation of Vitamin B could reduce plasma Hcy levels in stroke patients which might contribute to its effect in preventing stroke recurrence.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Dai G, Du H, Wang H, et al. [Preventive effect of Vitamin B supplementation on recurrent stroke: a Meta-analysis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2017. PMID: 28524030. doi:10.3760/cma.j.issn.2095-4352.2017.05.007

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。